LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 308 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,175,000 | +98.1% | 10,508 | +84.7% | 0.02% | +122.2% |
| Q4 2019 | $593,000 | -4.2% | 5,688 | -8.5% | 0.01% | -30.8% |
| Q3 2019 | $619,000 | -73.3% | 6,218 | -69.3% | 0.01% | -66.7% |
| Q2 2019 | $2,315,000 | +311.9% | 20,281 | +891.3% | 0.04% | +290.0% |
| Q3 2018 | $562,000 | +87.3% | 2,046 | -7.0% | 0.01% | +150.0% |
| Q3 2017 | $300,000 | +1.7% | 2,200 | -24.3% | 0.00% | +33.3% |
| Q4 2016 | $295,000 | +43.2% | 2,907 | +51.6% | 0.00% | 0.0% |
| Q1 2016 | $206,000 | -17.3% | 1,917 | -16.7% | 0.00% | -57.1% |
| Q4 2015 | $249,000 | -54.8% | 2,300 | -77.8% | 0.01% | -70.8% |
| Q4 2014 | $551,000 | -76.6% | 10,361 | -70.4% | 0.02% | -84.2% |
| Q1 2014 | $2,354,000 | -15.6% | 35,000 | -34.0% | 0.15% | +9.4% |
| Q4 2013 | $2,788,000 | +111.2% | 53,000 | +73.8% | 0.14% | +167.3% |
| Q3 2013 | $1,320,000 | +41.0% | 30,500 | +22.0% | 0.05% | 0.0% |
| Q2 2013 | $936,000 | – | 25,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |